Company presentation updated | IMGN Message Board Posts


IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  53858 of 54105  at  5/18/2022 10:13:41 AM  by

WilCravenMckrye


Company presentation updated


Goes into deeper details on the Soraya data.

https://investor.immunogen.com/static-files/900f3860-f6dd-4e43-bc62-6592c3db7792

I've been investing in biotechs for a long time. If the FDA doesn't accept the BLA I'm getting out of small biotechs in general as I fundamentally wouldn't understand what the FDA criteria is anymore in trial design.

That's not to say the company couldn't get a CRL on the submittal but it they do it's going to be for contract manufacturing control reasons which are solvable in a reasonable timeframe.







     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 3  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...